Erk1 and 2 are the most relevant MAPK components for breast cancer development [46], while the level of activated p38 expression is reported to be associated with the presence of lymph node metastasis in breast cancer [47]. This evidence concerns the gene MAPK3 and metastatic malignant neoplasm in the lymph nodes.